thomsonii polysaccharide (RPP-2), which has an α-D-1,3-glucan structure, can slow the release of TNF-α in HFD-induced NAFLD mice, reshape the Th17/Treg balance, and potentially treat nonalcoholic fatty liver disease [170]. Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.